MCI 📈 Barings Corporate Investors - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US06759X1072
MCI: Corporate Debt, Investment Grade Securities, Common Stocks
Babson Capital Corporate Investors trust is a closed ended fixed income mutual fund launched and managed by Barings LLC. It invests in fixed income markets of the United States. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in a portfolio of privately placed, below-investment grade, long term corporate debt obligations. The fund also invests in marketable investment grade debt securities, other marketable debt securities, and marketable common stocks. It was formerly known as Babson Capital Corporate Investors. Babson Capital Corporate Investors trust was formed in 1971 and is domiciled in the United States. Web URL: https://www.babsoncapital.com/Strategies/Trusts/MC
Additional Sources for MCI Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MCI Stock Overview
Market Cap in USD | 414m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 1985-07-01 |
MCI Stock Ratings
Growth 5y | 71.7% |
Fundamental | 38.4% |
Dividend | 95.7% |
Rel. Strength Industry | -21 |
Analysts | - |
Fair Price Momentum | 22.04 USD |
Fair Price DCF | 43.79 USD |
MCI Dividends
Dividend Yield 12m | 8.43% |
Yield on Cost 5y | 15.27% |
Annual Growth 5y | 11.98% |
Payout Consistency | 93.6% |
MCI Growth Ratios
Growth Correlation 3m | 85.6% |
Growth Correlation 12m | 81.8% |
Growth Correlation 5y | 87.8% |
CAGR 5y | 12.62% |
CAGR/Mean DD 5y | 1.42 |
Sharpe Ratio 12m | 0.93 |
Alpha | 5.39 |
Beta | 0.68 |
Volatility | 18.66% |
Current Volume | 41.7k |
Average Volume 20d | 40.1k |
What is the price of MCI stocks?
As of January 15, 2025, the stock is trading at USD 20.04 with a total of 41,700 shares traded.
Over the past week, the price has changed by -0.30%, over one month by +2.82%, over three months by +9.16% and over the past year by +23.41%.
As of January 15, 2025, the stock is trading at USD 20.04 with a total of 41,700 shares traded.
Over the past week, the price has changed by -0.30%, over one month by +2.82%, over three months by +9.16% and over the past year by +23.41%.
Is Barings Corporate Investors a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Barings Corporate Investors (NYSE:MCI) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.37 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MCI as of January 2025 is 22.04. This means that MCI is currently overvalued and has a potential downside of 9.98%.
Partly, yes. Based on ValueRay Fundamental Analyses, Barings Corporate Investors (NYSE:MCI) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.37 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MCI as of January 2025 is 22.04. This means that MCI is currently overvalued and has a potential downside of 9.98%.
Is MCI a buy, sell or hold?
Barings Corporate Investors has no consensus analysts rating.
Barings Corporate Investors has no consensus analysts rating.
What are the forecast for MCI stock price target?
According to ValueRays Forecast Model, MCI Barings Corporate Investors will be worth about 24.3 in January 2026. The stock is currently trading at 20.04. This means that the stock has a potential upside of +21.11%.
According to ValueRays Forecast Model, MCI Barings Corporate Investors will be worth about 24.3 in January 2026. The stock is currently trading at 20.04. This means that the stock has a potential upside of +21.11%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 24.3 | 21.1% |